Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleClinical StudiesR

Radioprotection

JOEL S. GREENBERGER
In Vivo March 2009, 23 (2) 323-336;
JOEL S. GREENBERGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: greenbergerjs@upmc.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cell, tissue and organ specific pathways of ionizing irradiation toxicity. Subtotal lung irradiation is shown as an example. Single alveolar pneumoncytes from an area within lung tissue are shown relative to total lung irradiation. Individual cells experience ionizing irradiation-induced production of radical oxygen species (ROS) including superoxide, hydroxyl radical, nitric oxide and peroxynitrite from the interaction of ionizing irradiation with oxygen and water. ROS interaction with pyrimidine and purine bases nuclear DNA produces single and double strand breaks, initiation of DNA repair, communication of DNA damage through the cell cytoplasm to the mitochondrial membrane via (stress activated protein (SAP) kinases) and then translation of pro-apoptotic, BCL2 family members from nucleus to mitochondria (86). Then follows mitochondrial membrane permeability, cytochrome c disassociation from cardiolipin, and cytoplasmic leakage of cytochrome c which leads to activation of the caspase-3 pathway and apoptosis (17-18, 86). Both dying and irradiated but recovering cells release ROS and inflammatory cytokines including IL-1, TNFα and TGFβ, which directly (through cell to cell contact with other cells in the tissue), and indirectly (via the circulation to cells at distant sites), produce acute local tissue and systemic effects respectively. Within the irradiated tissue differences in radiosensitivity of different cell phenotypes (endothelial cells, alveolar pneumocytes, alveolar macrophages and bronchopulmonary stem cells) contribute to the magnitude of tissue damage. The volume of tissue within the lung that is in the irradiation beam determines as does irradiation dose the magnitude of acute and chronic normal tissue effects.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Organ specific acute and chronic radiation toxicities. Acute tissue toxicity experienced during a radiotherapy treatment course or shortly thereafter is described as symptoms and signs of tissue damage for each organ (left side). Chronic radiation side-effects occurring months to years later are also shown (right). Severity and duration of both acute and chronic side-effects depends on radiation dose, dose rate, quality of irradiation (greater for high LET radiation beams) and volume of tissue treated.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Targets for development of radioprotector agents based on molecular pathways of the irradiation response. The molecular mechanism of irradiation damage in single cells (effects #1-4) and released inflammatory cytokines (effect #5) is defined by several target points where efforts for development of radioprotector drugs can focus. Radioprotectors could target the DNA damage step (121-122):(1); molecular translation of the DNA damage event to the mitochondria through the cytoplasm, (2); mitochondrial stabilization by preventing membrane permeability and leakage of cytochrome c, (3); activation of caspases to cause apoptosis (123), (4); or intracellular communication of cellular and tissue damage by elaboration of cytokines, (5). Examples of radioprotector drugs currently under development or in clinical trial are correlated to each irradiation effect and are shown in Table II.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

In Vivo: 23 (2)
In Vivo
Vol. 23, Issue 2
March-April 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radioprotection
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Radioprotection
JOEL S. GREENBERGER
In Vivo Mar 2009, 23 (2) 323-336;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Radioprotection
JOEL S. GREENBERGER
In Vivo Mar 2009, 23 (2) 323-336;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Ionizing Irradiation Clinical Effects
    • Ionizing Irradiation Toxic Effects
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Second-generation Probiotics Producing IL-22 Increase Survival of Mice After Total Body Irradiation
  • Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation
  • Antibiotic-induced shifts in fecal microbiota density and composition during hematopoietic stem cell transplantation
  • Unique epigenetic influence of H2AX phosphorylation and H3K56 acetylation on normal stem cell radioresponses
  • Silencing Egr1 Attenuates Radiation-Induced Apoptosis in Normal Tissues while Killing Cancer Cells and Delaying Tumor Growth
  • A Mobile Alert System for Preparing the Delivery of Radiation Mitigators
  • New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
  • The Zebrafish- Danio rerio - Is a Useful Model for Measuring the Effects of Small-molecule Mitigators of Late Effects of Ionizing Irradiation
  • Bactericidal/Permeability-Increasing Protein (rBPI21) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death
  • Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
  • Screening of Antimicrobial Agents for In Vitro Radiation Protection and Mitigation Capacity, Including those Used in Supportive Care Regimens for Bone Marrow Transplant Recipients
  • High-Throughput Screening Identifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones
  • Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
  • Google Scholar

More in this TOC Section

  • Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study
  • Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy
  • Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
Show more Clinical Studies

Similar Articles

In Vivo

© 2022 In Vivo

Powered by HighWire